L. Urban

Monitoring and tailoring the P2Y12 ADP receptor blocker therapy

D. Prídavková, T. Bolek, J. Benko, 2020 .

On-treatment platelet reactivity in the era of new ADP receptor blockers: data from a real-world clinical practice

P. Galajda, F. Kovář, T. Bolek, 2018, Acta Medica Martiniana.

Anti-Xa Activity in Elderly Xabans-Treated Patients With Atrial Fibrillation.

P. Galajda, M. Mokáň, T. Bolek, 2019, American journal of therapeutics.

Dabigatran levels in omeprazole versus pantoprazole-treated patients with atrial fibrillation: is there a difference?

M. Schnierer, P. Galajda, P. Bánovčin, 2019, European Journal of Clinical Pharmacology.

High­‑risk PCI using Shockwave intravascular lithotripsy and iVAC2L support in a Covid-19 positive patient: a case report

J. Sadloňová, L. Urban, I. Ságová, 2022, Intervenční a akutní kardiologie.

Myocardial free wall rupture as a complication of STEMI.

T. Bolek, M. Samoš, L. Urban, 2022, Vnitrni lekarstvi.

Dabigatran levels in omeprazole versus pantoprazole-treated patients with atrial fibrillation: is there a difference?

M. Schnierer, P. Galajda, P. Bánovčin, 2019, European Journal of Clinical Pharmacology.

High On-Treatment Platelet Reactivity in Patients Undergoing Complex Percutaneous Coronary Interventions

T. Bolek, M. Samoš, J. Žolková, 2023, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.